Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting
Read More
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Read More
Selvita to present new data from its oncology programs at the upcoming SITC 2018
Read More
Selvita presents new data from SEL120 program during Leukemia and Lymphoma – Europe and the USA Linking Knowledge and Practice
Read More
Selvita presents at the 25th Annual BioCentury NewsMakers in the Biotech Industry
Read More
Selvita to present new data from its oncology programs at the 6th Annual Immuno-Oncology Summit
Read More
Institute of Hematology and Transfusion Medicine and Selvita publish joint research results on SEL24 potential in Chronic Lymphocytic Leukemia
Read More
Selvita publishes research results on SEL24 in Oncotarget
Read More
Selvita to present new data from its oncology programs at the upcoming AACR Annual Meeting 2018
Read More
Selvita Announces Successful Completion of $41 M Book Building
Read More
